[1]魏丹,安喜燕,高军,等.不同OCT分型糖尿病黄斑水肿发病的影响因素分析[J].眼科新进展,2023,43(4):313-317.[doi:10.13389/j.cnki.rao.2023.0064]
　WEI Dan,AN Xiyan,GAO Jun,et al.Influencing factors on the attack of different types of diabetic macular edema classified by optical coherence tomography[J].Recent Advances in Ophthalmology,2023,43(4):313-317.[doi:10.13389/j.cnki.rao.2023.0064]
点击复制

不同OCT分型糖尿病黄斑水肿发病的影响因素分析/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
43卷
期数:
2023年4期
页码:
313-317
栏目:
应用研究
出版日期:
2023-04-05

文章信息/Info

Title:
Influencing factors on the attack of different types of diabetic macular edema classified by optical coherence tomography
作者:
魏丹; 安喜燕; 高军; 苏九妹
300170　天津市，天津市第三中心医院眼科，天津市重症疾病体外生命支持重点实验室，天津市人工细胞工程技术研究中心，天津市肝胆疾病研究所
Author(s):
WEI Dan; AN Xiyan; GAO Jun; SU Jiumei
Department of Ophthalmology,the Third Central Hospital of Tianjin,Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases,Artificial Cell Engineering Technology Research Center,Tianjin Institute of HepatobiliaryDisease,Tianjin 300170,China
关键词:
糖尿病黄斑水肿; 糖尿病肾病; 肾小球滤过率; 尿白蛋白尿肌酐比值
Keywords:
diabetic macular edema;  diabetic nephropathy;  glomerular filtration rate;  urinary albumin-creatinine ratio
分类号:
R774.5
DOI:
10.13389/j.cnki.rao.2023.0064
文献标志码:
A
摘要:
目的　探讨2型糖尿病患者不同光学相干断层成像（OCT）分型糖尿病黄斑水肿(DME)发病的影响因素。
方法　选取2019年1月至2021年12月天津市第三中心医院内分泌科确诊为2型糖尿病合并DME的患者117例117眼作为研究对象。由2位经验丰富的眼科医师依据患者OCT的黄斑区横断面图像对DME进行分型：弥漫性视网膜增厚(DRT)型、黄斑囊样水肿(CME)型、神经上皮脱离(NSD)型,如果患者双眼分型不一致，则取表现最为显著眼作为研究对象。收集患者年龄、病程（患者首次诊断糖尿病为起始时间）、体重指数(BMI)、入院后首次收缩压和舒张压、入院后首次空腹取外周血所得糖化血红蛋白(HbA1c)、随机尿白蛋白尿肌酐比值(UACR)、肾小球滤过率估算值(eGFR)、胱抑素C浓度(SCysC)等指标信息。分析不同DME分型与各指标的相关性并行无序多分类Logistic回归分析。
结果　117例DME患者中DRT型患者53例，CME型和NSD型患者各32例。NSD并Spearman相关分析结果显示：不同DME分型与收缩压、舒张压、UACR、SCysC均呈正相关（r=0.377、0.297、0.670、0.460，P=0.000、0.001、0.000、0.000）；与eGFR呈负相关（r=-0.507,P=0.000）；与HbA1c水平不相关（P>0.05）。以DME分型为因变量，以收缩压、舒张压、SCysC、eGFR、UACR为自变量，进行无序多分类Logistic回归分析。以DRT为参考类别，eGFR、UACR为不同DME分型发病的独立影响因素。即UACR水平越高、eGFR越低，患CME及NSD型DME的可能性越大。
结论　eGFR、UACR为不同DME分型发病的独立影响因素；UACR水平越高，eGFR越低，患CME及NSD型DME的可能性越大。
Abstract:
Objective　To explore the influencing factors of different types of diabetic macular edema (DME) in type 2 diabetes patients classified by optical coherence tomography (OCT).
Methods　A total of 117 patients (117 eyes) with type 2 diabetes combined with DME diagnosed by the Department of Endocrinology of Tianjin Third Central Hospital from January 2019 to December 2021 were selected as the subjects. Two experienced ophthalmologists classified the DME into the following types according to the cross-sectional images of the macular region in the OCT: diffuse retinal thickening (DRT), cystoid macular edema (CME), and neurosensory retinal detachment (NSD). If the classification of the patient’s two eyes was inconsistent, the more prominent eye was selected as the study object. Patient’s age, course of disease (the time when patients were first diagnosed with diabetes was regarded as the starting time), body mass index, the first measurement of systolic and diastolic blood pressure after admission, the first measurement of fasting glycosylated hemoglobin (HbAlc) in peripheral blood after admission, random urinary albumin-creatinine ratio (UACR), estimated glomerular filtration rate (eGFR), concentration of serum cystatin C (SCysC) and other indicators were collected. The correlation between different DME types and various indicators was analyzed, and the disordered multinomial logistic regression analysis was performed.
Results　Among the 117 DME patients, 53 had DRT, 32 had CME, and 32 had NSD. NSD and Spearman correlation analysis showed that different DME types were positively correlated with systolic and diastolic blood pressure, UACR and concentration of SCysC (r=0.377, 0.297, 0.670 and 0.460, P=0.000, 0.001, 0.000 and 0.000), negatively correlated with eGFR (r=-0.507, P=0.000), and not correlated with HbA1c level (P>0.05). With DME type as the dependent variable, and systolic and diastolic blood pressure, concentration of SCysC, eGFR and UACR as the independent variables, a disordered multinomial logistic regression analysis was conducted. Taking DRT as a reference, eGFR and UACR were independent influencing factors of different DME types. That is, the higher the UACR level and the lower the eGFR, the greater the possibility of CME and NSD.
Conclusion　The eGFR and UACR are independent influencing factors for different types of DME; the higher the UACR level and the lower the eGFR, the greater the possibility of CME and NSD.

参考文献/References:

［1］　BOSCIA F.Current approaches to the management of diabetic retinopathy and diabetic macular oedema［J］.Drugs,2010,70(16):2171-2200.
［2］　KANG J W,CHUNG H,CHAN K H.Correlation of optical coherence tomographic hyperrefletive foci with visual outcomes in different patterns of diabetic macular edema［J］.Retina,2016,36(9):1630-1639.
［3］　ACAN D,KARAHAN E,KOCAK N,KAYNAK S.Evaluation of systemic risk factors in different optical coherence tomographic patterns of diabetic macular edema［J］.Int J Ophthalmol,2018,11(7):1204-1209.
［4］　赵子君,梁丽芳,曾丽娜,柯晓云.不同OCT分型的糖尿病性黄斑水肿与血小板参数的关系［J］.眼科新进展,2020,40(5):453-456.
ZHAO Z J,LIANG L F,ZENG L N,KE X Y.Correlation of diabetic macular edema at different morphological patterns by OCT with platelet parameters［J］.Rec Adv Ophthalmol,2020,40(5):453-456.
［5］　中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017)［J］.中华糖尿病杂志,2018,10(1):4-67.
Diabetes Branch of Chinese Medical Association.Chinese guidelines for the prevention and treatment of type 2 diabetes(2017) ［J］.Chin J Diabetes Mellitus,2018,10(1):4-67.
［6］　中华医学会眼科学会眼底病学组.我国糖尿病视网膜病变临床诊疗指南(2014)［J］.中华眼科杂志,2014,50(11):851-865.
Chinese Ocular Fundus Diseases Society,Chinese Ophthalmological Society,Chinese Medical Association.Guidelines for clinical diagnosis and treatment of diabetic retinopathy in China(2014)［J］.Chin J Ophthalmol,2014,50(11):851-865.
［7］　严跃红,傅君舟,关昌杰,李剑文,洪明.三种CKD-EPI方程在我国糖尿病肾病患者中适用性的对比研究［J］.中华肾脏病杂志,2016,32(1):9-15.
YAN Y H,FU J Z,GUAN C J,LI J W,HONG M.Acomparative study on the applicability of three CKD-EPI equations for estimation of glomerular filtration rate in Chinese patients with diabetic nephropathy［J］.Chin J Nephrol,2016,32(1):9-15.
［8］　CHANG I B,LEE J H,KIM J S.Changes in choroidal thickness in and outside the macula after hemodialysis in patients with end-stage renal disease［J］.Retina,2017,37(5):896-905.
［9］　AMOAKU W M,GHANCHI F,BAILEY C,BANERJEE S,BANERJEE S,DOWNEY L,et al.Diabetic retinopathy and diabetic macular oedema pathways and management:UK Consensus Working Group［J］.Eye (Lond),2020,34(Suppl 1):1-51.
［10］　GHOSH S,BANSAL P,SHEJAO H,HEGDE R,ROY D,BISWAS S.Correlation of morphological pattern of optical coherence tomography in diabetic macular edema with systemic risckfacters in middle aged males［J］.Int Ophthalmol,2015,35(1):3-10.
［11］　HAMMER H P,WELP R,KEMPE H P,WAGNER C,SIEGEL E,HOLL R W,et al.Risk factors for retinopathy and DME in type 2 Diabetes-Results from the German/Austrian DPV database［J］.PLoS One,2015,10(7):e0132492.
［12］　DEHGHAN M H,KATIBEH M,AHMADIEH H,NOURINIA R,YASERI M.Prevalence and risk factors for diabetic retinopathy in the 40 to 80 year-old population in Yazd,Iran:the Yazd Eye Study［J］.J Diabetes,2015,7(1):139-141.
［13］　KEEL S,ITSIOPOULOS C,KOKLANIS K,VUKICEVIC M,CAMERON F,BRAZIONIS L.Prevalence and risk factors for diabeticretinopathy in a hospital-based population of Australian childrenand adolescents with type 1 diabetes［J］.J Pediatr Endocrinol Metab,2016,29(10):1135-1142.
［14］　MAISEL A S.Cardiovascular and renal surrogate markers inthe clinical management ofhypertension［J］.Cardiovasc Drugs Ther,2009,23(4):317-326.
［15］　李玮,杜新华,李淑婷,王相宁,陈永东,吴强.糖尿病黄斑水肿相干断层扫描分型与糖尿病视网膜分期及全身因素的相关性分析［J］.中华眼底病杂志,2017,33(3):262-266.
LI W,DU X H,LI S T,WANG X N,CHEN Y D,WU Q.Optical coherence tomography distribution patterns of diabetic macular edema and its correlations with diabetic retinopathy stages and systemic factors［J］.Chin J Ocul Fundus Dis,2017,33(3):262-266.
［16］　YAU J W,ROGERS S L,KAWASAKI R,LAMOUREUX E L,KOWALSKI J W,BEK T,et al.Global prevalence and major risk factors of diabetic retinopathy［J］.Diabetes Care,2012,35(3):556-564.
［17］　WONG B S,SHARANJEET K S,NGAH N F,SAWRI R R.The correlation between hemoglobin A1c(HbA1c)and hyperreflective dots(HRD)in diabetic patients［J］.Int J Environ Res Public Health,2020,17(9):3154.
［18］　张会芬,杨宏秀,刘丽,袁宝军.血清中性粒细胞明胶酶相关脂质运载蛋白、胱抑素C及尿白蛋白肌酐比值、N-乙酰-β-D-氨基葡萄糖苷酶检测在早期糖尿病肾脏疾病中的应用价值［J］.中国糖尿病病杂志,2018,26(4):309-315.
ZHANG H F,YANG H X,LIU L,YUAN B J.Application value of serum neutrophil gelatinase-associated lipocalin,cystatinC,urinary albumin creatinine rate and N-acetyl-β-D-glucosaminidase in early diabetic kidney disease［J］.Chin J Diabetes,2018,26(4):309-315.
［19］　冯雪凤,李爱梅,许守林,贾鹏,沈山梅.肾小球滤过率、尿微量白蛋白、血β2-微球蛋白和胱抑素C诊断糖尿病肾病的临床价值［J］.中华核医学与分子影像杂志,2017,37(6):331-336.
FENG X F,LI A M,XU S L,JIA P,SHEN S M.Diagnostic value of glomerular filtration rate,microalbuminuria,β2-microglobulin and cystatin C for renal function in patients with diabetic nephropathy［J］.Chin J Nucl Mol Imaging,2017,37(6):331-336.
［20］　TSAI M J,HSIEH Y T,SHEN E P,PENG Y J.Systemic associations with residualsubretinal fluid after Ranibizumabindiabetic macular edema［J］.J Ophthalmol,2017,2017:4834201．
［21］　魏忠燕,谢立科,镇华,秦睿,张明明,郝晓凤,等.同型半胱氨酸,尿酸,乳酸脱氢酶及肌酸激酶与糖尿病视网膜病变的关系［J］.眼科新进展,2011,31(9):846-848.
WEI Z Y,XIE L K,ZHEN H,QIN R,ZHANG M M,HAO X F,et al.Correlation of homocysteine,uricacid,lactate dehydrogenase and creatine kinase with diabetic retinopathy［J］.Rec Adv Ophthalmol,2011,31(9):846-848.

相似文献/References:

[1]赵倩 金学民.Avastin联合黄斑格栅样光凝治疗糖尿病黄斑水肿的临床研究[J].眼科新进展,2013,33(2):000.
[2]沈强 张学东.糖尿病黄斑水肿的发病机制及治疗进展[J].眼科新进展,2012,32(2):000.
[3]吕金雷 吕柳青 邵毅 杨岭 曾艳 肖红波 陈钦开.缬沙坦联合己酮可可碱治疗糖尿病肾病及视网膜病变的研究[J].眼科新进展,2012,32(10):000.
[4]赵勇 张卯年 任兵.激素缓释系统治疗糖尿病黄斑水肿新进展[J].眼科新进展,2012,32(10):000.
[5]曹薇 崔红平 张美萍.23G微切口玻璃体切割手术治疗糖尿病视网膜病变[J].眼科新进展,2013,33(11):000.
[6]肖红波,吕金雷,邵毅,等.非诺贝特治疗糖尿病视网膜病变合并肾病的临床研究[J].眼科新进展,2014,34(12):1132.[doi:10.13389/j.cnki.rao.2014.0314]
　XIAO Hong-Bo,LV Jin-Lei.SHAO Yi,YU Yao,et al.Fenofibrate for diabetic retinopathy combined with diabetic nephropathy[J].Recent Advances in Ophthalmology,2014,34(4):1132.[doi:10.13389/j.cnki.rao.2014.0314]
[7]刘斌,杨玉霞,刘杏,等.玻璃体内注射Lucentis治疗糖尿病黄斑水肿[J].眼科新进展,2015,35(1):045.[doi:10.13389/j.cnki.rao.2015.0013]
　LIU Bin,YANG Yu-Xia,LIU Xing,et al.Intravitreal injection of Lucentis for diabetic macular edema[J].Recent Advances in Ophthalmology,2015,35(4):045.[doi:10.13389/j.cnki.rao.2015.0013]
[8]王博,吴京,马明,等. 玻璃体内注射雷珠单抗与曲安奈德治疗糖尿病黄斑水肿的疗效对比分析[J].眼科新进展,2015,35(3):246.[doi:10.13389/j.cnki.rao.2015.0066]
　WANG Bo,WU Jing,MA Ming,et al. Clinictid effect comparison of intravitreal lucentis and triamcinolone acetonide for diabetic macular edema[J].Recent Advances in Ophthalmology,2015,35(4):246.[doi:10.13389/j.cnki.rao.2015.0066]
[9]徐浩,白宁艳,吕鹏,等. 雷珠单抗玻璃体内注射与黄斑部格栅样光凝联合治疗糖尿病性黄斑水肿的疗效观察[J].眼科新进展,2015,35(8):781.[doi:10.13389/j.cnki.rao.2015.0215]
　XU Hao,BAI Ning-Yan,LV Peng,et al. Intravitreous injection of ranibizumab combined with macular grid photocoagulation for diabetic macular edema[J].Recent Advances in Ophthalmology,2015,35(4):781.[doi:10.13389/j.cnki.rao.2015.0215]
[10]董秀清,冯松福,柯晓云.应用光学相干断层扫描量化评估糖尿病黄斑水肿的临床研究[J].眼科新进展,2017,37(2):133.[doi:10.13389/j.cnki.rao.2017.0035]
　DONG Xiu-Qing,FENG Song-Fu,KE Xiao-Yun.Evaluating diabetic macular edema quantificationally by optical coherence tomography[J].Recent Advances in Ophthalmology,2017,37(4):133.[doi:10.13389/j.cnki.rao.2017.0035]

更新日期/Last Update: 2023-04-05